Stem Cell Research (Apr 2022)

Generation an induced pluripotent stem cell line SXMUi001-A derived from a hemophilia B patient carries variant F9 c.223C>T(p.R75X)

  • Yanchun Ma,
  • Wenwen Sun,
  • Xiue Liu,
  • Juan Ren,
  • Xialin Zhang,
  • Ruijuan Zhang,
  • Lidong Zhao,
  • Linhua Yang,
  • Gang Wang

Journal volume & issue
Vol. 60
p. 102684

Abstract

Read online

Hemophilia B (HB) is an X chromosome-linked recessive disorder caused by a quantitative or qualitative defect of coagulation zymogen factor IX. In this study, urine cells were collected from a patient with HB who carries variant F9 c.223C > T (p.R75X), and reprogrammed into induced pluripotent stem cells (iPSCs) using the reprogramming factors, OCT4, SOX2, m-MYC, and KLF4. The HB-iPSC line (SXMUi001-A) has characteristics similar to human embryonic stem cell, namely, pluripotency and the potential to differentiate into three germ layers. This cell line can be used as a disease model for exploring the molecular mechanism and readthrough treatment of HB.